USD
+$0.00
(+0.00%
)At Close (As of Oct 10, 2025)
$5.28M
Market Cap
0.0029
P/E Ratio
62.6
EPS
$60.00
52 Week High
$0.06
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$84K |
Total Revenue | $0 |
Cost Of Revenue | $84K |
Costof Goods And Services Sold | $84K |
Operating Income | -$25M |
Selling General And Administrative | $8.7M |
Research And Development | $16M |
Operating Expenses | $25M |
Investment Income Net | - |
Net Interest Income | -$165K |
Interest Income | $70K |
Interest Expense | $235K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $84K |
Income Before Tax | -$1.8M |
Income Tax Expense | $3.7M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$1.8M |
Comprehensive Income Net Of Tax | - |
Ebit | -$1.6M |
Ebitda | -$1.5M |
Net Income | -$5.5M |
Field | Value (USD) |
---|---|
Total Assets | $28M |
Total Current Assets | $2.6M |
Cash And Cash Equivalents At Carrying Value | $1.8M |
Cash And Short Term Investments | $1.8M |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $25M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $24M |
Intangible Assets Excluding Goodwill | $24M |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $795K |
Other Non Current Assets | - |
Total Liabilities | $18M |
Total Current Liabilities | $5.7M |
Current Accounts Payable | $1.9M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $841K |
Total Non Current Liabilities | $12M |
Capital Lease Obligations | $1.2M |
Long Term Debt | - |
Current Long Term Debt | $661K |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $1.8M |
Other Current Liabilities | $2.7M |
Other Non Current Liabilities | $3.8M |
Total Shareholder Equity | $10M |
Treasury Stock | - |
Retained Earnings | -$847M |
Common Stock | $305K |
Common Stock Shares Outstanding | $53K |
Field | Value (USD) |
---|---|
Operating Cashflow | -$15M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $84K |
Capital Expenditures | $12K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$12K |
Cashflow From Financing | $13M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | $657K |
Dividend Payout Common Stock | $657K |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$1.9M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$1.8M |
Field | Value (USD) |
---|---|
Gross Profit | -$84K |
Total Revenue | $0 |
Cost Of Revenue | $84K |
Costof Goods And Services Sold | $84K |
Operating Income | -$25M |
Selling General And Administrative | $8.7M |
Research And Development | $16M |
Operating Expenses | $25M |
Investment Income Net | - |
Net Interest Income | -$165K |
Interest Income | $70K |
Interest Expense | $235K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $84K |
Income Before Tax | -$1.8M |
Income Tax Expense | $3.7M |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$1.8M |
Comprehensive Income Net Of Tax | - |
Ebit | -$1.6M |
Ebitda | -$1.5M |
Net Income | -$5.5M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Windtree Therapeutics, Inc., a clinical-stage biotechnology and medical device company, focuses on the development of therapies for the treatment of acute pulmonary and cardiovascular diseases.